1 Min Read
(Corrects headline to fix typo)
Nov 13 (Reuters) - Hologic Inc (HOLX.O): * Releases the results of the Cervista HPV clinical trials * Says clinical trial met or exceeded all of target end points
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.